IART · Integra Lifesciences Holdings Corp
$18.34
+0.10 (+0.55%)
At close · Aug 14
Market Cap
$1.43B
Shares
77.77M
Integra Lifesciences Holdings Corp Earnings Call Transcripts
Every quarterly earnings call for Integra Lifesciences Holdings Corp (IART) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼0.4%
$385.19M
$49.91M
'22 Q3
22-10-26
▼1.8%
$398.02M
$52.95M
'22 Q4
23-01-10
▲1.1%
$380.85M
$24.23M
'23 Q1
23-04-26
▼4.2%
$381.27M
$4.18M
'23 Q2
23-07-27
▼0.7%
$382.42M
$19.50M
'23 Q3
23-10-25
▼0.2%
$397.04M
$19.83M
'23 Q4
24-02-28
▼3.1%
$368.87M
−$3.28M
'24 Q1
24-05-06
▲9.7%
$418.18M
−$12.40M
'24 Q2
24-07-29
▼0.4%
$380.83M
−$10.70M
'24 Q3
24-11-04
▲11.5%
$442.65M
$19.43M
'24 Q4
25-02-25
▲3.7%
$382.65M
−$25.29M
'25 Q1
25-05-05
▼0.6%
$415.61M
−$484.07M
'25 Q2
25-07-31
▲5.6%
$402.06M
−$5.40M
'25 Q3
25-10-30
▼1.7%
$434.93M
−$1.70M
'25 Q4
26-02-26
▲2.4%
$391.92M
−$4.62M
'26 Q1
26-05-05
LATEST
▲0.8%
$418.76M
$4.48M
'26 Q2
26-07-29
Earnings call
FY26 · Q2
2026-07-29
Integra LifeSciences Q2’2026 Earnings Call
Positive tone
Surgimend/Durazorb relaunch and PMA strategy
Second quarter financial performance
Tissue reconstruction and wound care
Revenue
$418.76M
▲ 0.8% YoY Diluted EPS
$0.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-16
Truist Securities MedTech Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Integra Lifesciences Holdings Corp Q1 FY2026 Earnings Call
Positive tone
Q1 Financial Results
CEO Transition and Leadership Change
Margins and Transformation
Revenue
$391.92M
▲ 2.4% YoY Diluted EPS
$-0.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Integra Lifesciences Holdings Corp Q4 FY2025 Earnings Call
Positive tone
2026 financial guidance
Portfolio segment performance (CSS and Tissue)
Supply chain reliability and product relaunches
Revenue
$434.93M*
▼ 1.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Integra Lifesciences Holdings Corp Q3 FY2025 Earnings Call
Positive tone
Product relaunches (PriMatrix and Durepair)
Compliance Master Plan and FDA remediation
Supply chain and operational execution
Revenue
$402.06M
▲ 5.6% YoY Diluted EPS
$-0.07
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Integra Lifesciences Holdings Corp Q2 FY2025 Earnings Call
Positive tone
ENT / Acclarent Franchise
Revenue and EPS Guidance
Compliance Master Plan and Quality Remediation
Revenue
$415.61M
▼ 0.6% YoY Diluted EPS
$-6.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Integra Lifesciences Holdings Corp Q1 FY2025 Earnings Call
Cautious tone
Tariffs and mitigation
Organic vs. reported revenue growth
Ship holds / supply disruption
Revenue
$382.65M
▲ 3.7% YoY Diluted EPS
$-0.33
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Integra Lifesciences Holdings Corp Q4 FY2024 Earnings Call
Cautious tone
Manufacturing and Supply Chain Recovery
Portfolio Growth and Innovation
Compliance Master Plan and FDA Remediation
Revenue
$442.65M*
▲ 11.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Integra Lifesciences Holdings Corp Q3 FY2024 Earnings Call
Cautious tone
Acclarent / ENT Business
Supply Constraints and Revenue Impact
2025 Guidance and Share Recapture
Revenue
$380.83M
▼ 0.4% YoY Diluted EPS
$-0.14
▼ 158.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-29
Integra Lifesciences Holdings Corp Q2 FY2024 Earnings Call
Cautious tone
Acclarent integration and ENT franchise
Compliance master plan and quality systems remediation
Tissue Technologies portfolio strength
Revenue
$418.18M
▲ 9.7% YoY Diluted EPS
$-0.16
▼ 420% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Integra Lifesciences Holdings Corp Q1 FY2024 Earnings Call
Cautious tone
Acclarent acquisition and ENT expansion
Boston plant remediation and recall
Guidance and financial outlook
Revenue
$368.87M
▼ 3.1% YoY Diluted EPS
$-0.04
▼ 113.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Integra Lifesciences Holdings Corp Q4 FY2023 Earnings Call
Balanced tone
Acclarent ENT acquisition
Boston recall and manufacturing recovery
Financial results and 2024 guidance
Revenue
$397.04M*
▼ 0.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Integra Lifesciences Holdings Corp Q3 FY2023 Earnings Call
Revenue
$382.42M
▼ 0.7% YoY Diluted EPS
$0.24
▼ 60% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Integra Lifesciences Holdings Corp Q2 FY2023 Earnings Call
Revenue
$381.27M
▼ 4.2% YoY Diluted EPS
$0.05
▼ 90.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Integra Lifesciences Holdings Corp Q1 FY2023 Earnings Call
Revenue
$380.85M
▲ 1.1% YoY Diluted EPS
$0.29
▼ 25.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-10
Integra Lifesciences Holdings Corp Q4 FY2022 Earnings Call
Revenue
$398.02M*
▼ 1.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-26
Integra Lifesciences Holdings Corp Q3 FY2022 Earnings Call
Revenue
$385.19M
▼ 0.4% YoY Diluted EPS
$0.60
▲ 17.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
Integra Lifesciences Holdings Corp Q2 FY2022 Earnings Call
Revenue
$397.81M
▲ 2% YoY Diluted EPS
$0.54
▲ 31.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Integra Lifesciences Holdings Corp Q1 FY2022 Earnings Call
Revenue
$376.64M
▲ 4.6% YoY Diluted EPS
$0.39
▼ 26.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Integra Lifesciences Holdings Corp Q4 FY2021 Earnings Call
Revenue
$405.52M*
▲ 4.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Integra Lifesciences Holdings Corp Q3 FY2021 Earnings Call
Revenue
$386.86M
▲ 4.5% YoY Diluted EPS
$0.51
▲ 34.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Integra Lifesciences Holdings Corp Q2 FY2021 Earnings Call
Revenue
$389.99M
▲ 50.8% YoY Diluted EPS
$0.41
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-28
Integra Lifesciences Holdings Corp Q1 FY2021 Earnings Call
Revenue
$360.07M
▲ 1.6% YoY Diluted EPS
$0.53
▲ 381.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-14
Integra Lifesciences Holdings Corp Q4 FY2020 Earnings Call
Revenue
$388.65M
▼ 1.6% YoY Diluted EPS
$1.09
▲ 505.6% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-06
Integra Lifesciences Holdings Corp Q3 FY2020 Earnings Call
Revenue
$370.23M
▼ 2.3% YoY Diluted EPS
$0.38
Gross margin
63.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-09
Integra Lifesciences Holdings Corp Q2 FY2020 Earnings Call
Revenue
$258.67M
▼ 32.6% YoY Diluted EPS
$0.00
▼ 100% YoY Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-07
Integra Lifesciences Holdings Corp Q1 FY2020 Earnings Call
Revenue
$354.32M
▼ 1.5% YoY Diluted EPS
$0.11
▼ 71.1% YoY Gross margin
62.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-14
Integra Lifesciences Holdings Corp Q4 FY2019 Earnings Call
Revenue
$395.13M
▲ 3.1% YoY Diluted EPS
$0.18
▼ 37.9% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–29 of 29 earnings calls
Key facts
CIK
917520
CUSIP
457985208
13F (30d)
196 filings
194 filers
Visit website
Investor relations